Role of maternal humoral immunity in vertical transmission of HIV-1 subtype E in Thailand

J Acquir Immune Defic Syndr. 1999 Aug 1;21(4):259-65. doi: 10.1097/00126334-199908010-00001.

Abstract

The significance of the maternal humoral immune response in relation to vertical transmission of HIV-1 was investigated in 123 mothers infected with subtype E from Thailand. Antibody binding titers to HIV-1 env domains (monomeric gp120, the CD4/gp120 binding site [BS], V3 loop, and gp41) and antibody-mediated neutralization of primary and T-cell line-adapted (TCLA) subtypes B and E HIV-1 isolates were investigated. No correlation between maternal anti HIV-1 antibodies at delivery and vertical transmission of HIV-1 subtype E was found. However, a trend to higher titer antibody-mediated cross-neutralization of a heterologous subtype B TCLA isolate, HIV-1MN, was observed in nontransmitting mothers postpartum. The HIV-1-specific antibody titers in these infected mothers increased significantly from delivery to 6 months postpartum (p < .05), but this was only partially attributable to hemodilution and an additional factor or factors appear to affect humoral immunity to HIV-1 during late pregnancy.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Amino Acid Sequence
  • Cohort Studies
  • Female
  • HIV Antibodies / blood*
  • HIV Envelope Protein gp120 / genetics
  • HIV Envelope Protein gp120 / immunology
  • HIV Envelope Protein gp41 / genetics
  • HIV Envelope Protein gp41 / immunology
  • HIV Infections / complications*
  • HIV Infections / immunology
  • HIV Infections / transmission*
  • HIV-1 / classification*
  • HIV-1 / genetics
  • HIV-1 / immunology*
  • Humans
  • Immunity, Maternally-Acquired
  • Infant
  • Infant, Newborn
  • Infectious Disease Transmission, Vertical*
  • Molecular Sequence Data
  • Neutralization Tests
  • Peptide Fragments / genetics
  • Peptide Fragments / immunology
  • Pregnancy
  • Pregnancy Complications, Infectious / immunology*
  • Thailand

Substances

  • HIV Antibodies
  • HIV Envelope Protein gp120
  • HIV Envelope Protein gp41
  • HIV envelope protein gp120 (305-321)
  • Peptide Fragments